These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20180514)

  • 1. Controlled cisplatin delivery from Ureasil-PEO1900 hybrid matrix.
    Molina EF; Pulcinelli SH; Santilli CV; Blanchandin S; Briois V
    J Phys Chem B; 2010 Mar; 114(10):3461-6. PubMed ID: 20180514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand exchange inducing efficient incorporation of CisPt derivatives into Ureasil-PPO hybrid and their interactions with the multifunctional hybrid network.
    Molina EF; Pulcinelli SH; Santilli CV; Briois V
    J Phys Chem B; 2012 Jul; 116(27):7931-9. PubMed ID: 22676472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release kinetics of ampicillin, characterization and bioactivity of TiO2/PCL hybrid materials synthesized by sol-gel processing.
    Catauro M; Raucci MG; de Marco D; Ambrosio L
    J Biomed Mater Res A; 2006 May; 77(2):340-50. PubMed ID: 16404715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Poly(ethylene glycol)s.
    Obermeier B; Wurm F; Mangold C; Frey H
    Angew Chem Int Ed Engl; 2011 Aug; 50(35):7988-97. PubMed ID: 21751305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibly PEGylated nanocarrier for cisplatin delivery.
    Stoyanova E; Mitova V; Shestakova P; Kowalczuk A; Momekov G; Momekova D; Marcinkowski A; Koseva N
    J Inorg Biochem; 2013 Mar; 120():54-62. PubMed ID: 23318287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and drug release properties of poly(ethylene oxide) segmented polysulfone copolymers.
    Gu X; Kuang Y; Guo X; Fang J; Ni Z
    J Control Release; 2008 May; 127(3):267-72. PubMed ID: 18353482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel hydrogel membrane based on copoly(hydroxyethyl methacrylate/p-vinylbenzyl-poly(ethylene oxide)) for biomedical applications: properties and drug release characteristics.
    Arica MY; Bayramoglu G; Arica B; Yalçin E; Ito K; Yagci Y
    Macromol Biosci; 2005 Oct; 5(10):983-92. PubMed ID: 16208632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular hydrogels based on self-assembly between PEO-PPO-PEO triblock copolymers and alpha-cyclodextrin.
    Ni X; Cheng A; Li J
    J Biomed Mater Res A; 2009 Mar; 88(4):1031-6. PubMed ID: 18404710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sol-gel organic-inorganic hybrid materials for drug delivery.
    Catauro M; Verardi D; Melisi D; Belotti F; Mustarelli P
    J Appl Biomater Biomech; 2010; 8(1):42-51. PubMed ID: 20740421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic characterization and electrochemistry of poly(ethylene oxide)-modified myoglobin in organic solvents.
    Wiwatchaiwong S; Nakamura N; Ohno H
    Biotechnol Prog; 2006; 22(5):1276-81. PubMed ID: 17022664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M
    J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and alpha-cyclodextrin.
    Li J; Ni X; Leong KW
    J Biomed Mater Res A; 2003 May; 65(2):196-202. PubMed ID: 12734812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a drug to structure its release matrix and release profile.
    Brook MA; Holloway AC; Ng KK; Hrynyk M; Moore C; Lall R
    Int J Pharm; 2008 Jun; 358(1-2):121-7. PubMed ID: 18407444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug release from and hydrolytic degradation of a poly(ethylene glycol) grafted poly(3-hydroxyoctanoate).
    Kim HW; Chung CW; Hwang SJ; Rhee YH
    Int J Biol Macromol; 2005 Jul; 36(1-2):84-9. PubMed ID: 15936069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sol-gel phosphate-based glass for drug delivery applications.
    Pickup DM; Newport RJ; Knowles JC
    J Biomater Appl; 2012 Jan; 26(5):613-22. PubMed ID: 20819917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfouling biomaterials based on polyethylene oxide-containing amphiphilic triblock copolymers as surface modifying additives: solid state structure of PEO-copolymer/polyurethane blends.
    Tan J; Brash JL
    J Biomed Mater Res A; 2008 Jun; 85(4):862-72. PubMed ID: 17896775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.